STOCKHOLM, Sweden, June 17, 2003 (PRIMEZONE) -- Stockholm International Fairs: now in its fourth year, BioTech Forum has rapidly transformed into the largest and most influential Scandinavian meeting place for the biotech industry and a primary networking event on the European scientific circuit. The annual exhibition today represents a leading international venue for all aspects of biotechnology and is widely recognised as an essential date in the biotech calendar.
Sweden and its Scandinavian neighbours have a long standing tradition for excellence in the medical field as has been seen with the high proportion of scientific products and companies that have made positive impacts on global health. In recent years the advanced collaboration that exists between basic research and the business and financial communities has been strengthened at local, national and international levels to ensure that more biotechnology breakthroughs are brought to the market-place.
BioTech Forum
As well as dealing with issues in pharmaceuticals and medicine, ethics, and patent issues, BioTech Forum also provides access to venture capital, B2B-partnerships, science parks, biotechnology clusters and university programmes. A winning formula has been achieved by hosting an exhibition co-hosted by a Science Conference, B2B Partnering Event and an Investment and Partnership Forum that encompasses the numerous components of a complex industry.
BioTech Forum Exhibition 2003
BioTech Forum 2003 will run at Stockholm International Fairs on November 26-28 concurrently with Scandinavia's largest event for the medical profession and health care sector, organized in conjunction with the annual General Meeting by the Swedish Society of Medicine. Some 220 companies from 10 countries will participate in the exhibition.
BioTech Forum Science Conference 2003
A conference with focus on the science upon which the biotechnology sector will develop and progress is arranged by Karolinska Institutet in collaboration with the Swedish Academy of Pharmaceutical Sciences. The conference will include special topics such as Autoimmune Diseases, Informatic, Metabolic Diseases and Proteomics. This year's Scheele lecturer Jonathan A. Ellmen, University of California, USA, will talk about Systems-Bases Combinatorial.
BioTech Forum B2B
Partnering Event Business Arena Stockholm is organising the B2B partnering event where companies are given the opportunity to meet with prospective business companies from the Swedish Biotech market in pre-booked meetings.
CONNECT Biomedical Partnership Forum 2003
CONNECT in the Nordic-Baltic area is organising its annual investment and partnership forum for young innovative biomedical companies.